• Home
  • News
    • Editorial
    • MD(e)B(unker)
    • Related Researches
      • Di Bella's Foundation
      • 1960-1969
      • 1970-1979
      • 1980-1989
      • 1990-1999
      • 2000-2009
      • 2010-2019
      • 2020-2029
    • Science news
    • Scientific Documentation
  • About us...
    • Biography
    • Bibliography
  • The Method
    • Di Bella's Method!
    • 1998 Trial!
  • Media
    • Video Publications
    • News-PapersNews-Papers
      • Press
    • TestimonialTestimonial
      • Testimonies
    • Video GalleryVideo Gallery
      • Congresses
      • Video Testimonies
      • TV & C.
  • Case History
    • Medical reports
      • Lung
      • Lymphomas
        • Non-Hodgkin Lymphomas
        • Hodgkin Lymphomas
      • Mediastinum
      • Mesothelioma
      • Myeloma
      • Pancreas
      • Scientific Publications
  • F.A.Q.
  • Useful Links
    • User Side
      • Vademecum
    • CouponChief - Resources for Cancer Patients
  • Contact Us
Home page   News   Related Researches   2000-2009  
Title Created Date
Melatonin: An Endogenous Antiestrogen with Oncostatic Properties 02 January 2026
Melatonin protects rat liver against irradiation-induced oxidative injury 12 December 2025
Melatonin: new places in therapy 14 October 2025
MT-1 melatonin receptor expression increases the antiproliferative effect of melatonin on S-91 murine melanoma cells 14 October 2025
Different responsiveness of central nervous system tissues to oxidative conditions and to the antioxidant effect of melatonin 06 October 2025
Correlation between nuclear melatonin receptor expression and enhanced cytokine production in human lymphocytic and monocytic cell lines 06 October 2025
Chemical and physical properties and potential mechanisms: melatonin as a broad spectrum antioxidant and free radical scavenger 29 July 2025
Chemotactic effect of melatonin on leukocytes 29 July 2025
Biochemical reactivity of melatonin with reactive oxygen and nitrogen species: a review of the evidence 08 July 2025
Anti-inflammatory actions of melatonin and its metabolites, N1-acetyl-N2-formyl-5-methoxykynuramine (AFMK) and N1-acetyl-5-methoxykynuramine (AMK), in macrophages 24 June 2025
Display # 

Page 1 of 110

  • Start
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • Next
  • End

Search

Follow us...

Latest

  • Modulation of Radiation-induced Base Excision Repair Pathway Gene Expression by Melatonin
  • Melatonin, circadian rhythms and breast cancer
  • Melatonin Modulation of Radiation and Chemotherapeutics-induced Changes on Differentiation of Breast Fibroblasts
  • THERAPY WITH SOMATOSTATIN ANALOGUES IN PATIENTS WITH CASTRATION-REFRACTORY PROSTATE CANCER
  • Melatonin modulation of crosstalk among malignant epithelial, endothelial and adipose cells in breast cancer (Review)
  • Melatonin May Increase Anticancer Potential of Pleiotropic Drugs
  • Melatonin inhibits growth of B16 melanoma in C57BL/6 mice
  • Melatonin induces the apoptosis and inhibits the proliferation of human gastric cancer cells via blockade of the AKT/MDM2 pathway
  • Melatonin induces mitochondrial-mediated apoptosis in human myeloid HL-60 cells
  • Melatonin induces apoptosis through biomolecular changes, in SK-LU-1 human lung adenocarcinoma cells
  • Melatonin Enhances the Usefulness of Ionizing Radiation: Involving the Regulation of Different Steps of the Angiogenic Process
  • Melatonin enhances the apoptotic effects and modulates the changes in gene expression induced by docetaxel in MCF‑7 human breast cancer cells
  • Exceptional and typical biomarker responses to AminoTriComplex in metastatic prostate cancer: a case series
  • Dotatate PET/CT and 225Ac-Dotatate Therapy for Somatostatin Receptor-expressing Metastatic Breast Cancer
  • Application of chitosan and its derivatives in immunotherapy of malignant neoplasms
  • A 28-year prospective analysis of serum vitamin E, vitamin E-related genetic variation and risk of prostate cancer
  • Melatonin as an adjuvant in radiotherapy for radioprotection and radiosensitization
  • Melatonin as a Therapeutic Agent for the Inhibition of Hypoxia-Induced Tumor Progression: A Description of Possible Mechanisms Involved

Most Read

  • The Di Bella Method (DBM)
  • About melatonin - 1996
  • All-trans-retinoic acid and cancer
  • Biography
  • The Di Bella Method Increases by the 30% the survival rate for Pancreas tumors and for this reason should be proposed as first line therapy for this type of cancer
  • Chronic Lymphocytic Leukemia: 4 patients, long-lasting remission
  • Somatostatin in oncology, the overlooked evidences
  • Treatment of Low-grade Non-Hodgkin’s Lymphomas at Advanced Stage
  • How effective is chemo therapy?
  • Bibliography
  • Complete objective response to biological therapy of plurifocal breast carcinoma
  • Large B-cells Non-Hodgkin's Lymphoma, Stage IV-AE: a Case Report
  • Non-Hodgkin's Lymphoma, Stage III-B-E: a Case Report
  • Vademecum
  • Frequently Asked Questions
  • Declaration recommends eliminate the use of Impact factor for research evaluation
  • Non–Small-Cell Lung Cancer Patients with Low Performance Status: study on 28 patients
  • Breast cancer: study on 122 cases. The Di Bella Method (DBM) improved survival, objective response and performance status in a retrospective observational clinical study on 122 cases of breast cancer